Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should
be considered in evaluating our outlook include, but
are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build
rates of certain aircraft; 6) the effect on aircraft demand and build
rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency
exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount
rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or
at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that
was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit
ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not
be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest
rates increase substantially; 27) the effectiveness of any interest
rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign
current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These amounts
are derived by translating
current year results
at prior year average
exchange rates.
At current exchange rates, that
's over $ 33.6 million, according to a statement from the New York FBI
's office.
Comment: Despite some macro slowdown and stock market gyrations in China, we remain confident in our $ 625 million forecast for FY 2016 even
at current exchange rates and optimistic on the prospects for this market over the long - term as the drivers we've consistently mentioned
are more relevant than ever,» said CEO Victor Luis.
While the government announcement appeared to require all funds
be returned to investors, Da said he can't force people to
exchange their tokens as they would lose out
at bitcoin's
current rate.
They
are calculated by translating
current and prior - period sales
at the same predetermined
exchange rate.
The monthly payment of 700,000 bolivars
is,
at the
current exchange rate, worth about $ 3.83, according to CNN.
System - wide sales growth and comparable sales
are measured on a constant currency basis, which means that results exclude the effect of foreign currency translation and
are calculated by translating prior year results
at current year monthly average
exchange rates.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may
be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and
current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore
be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign
exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange rate of the U.S. dollar that may cause an unfavorable foreign currency
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and
Exchange Commission (t
Exchange Commission (the SEC).
These risks include, in no particular order, the following: the trends toward more high - definition, on - demand and anytime, anywhere video will not continue to develop
at its
current pace or will expire; the possibility that our products will not generate sales that
are commensurate with our expectations or that our cost of revenue or operating expenses may exceed our expectations; the mix of products and services sold in various geographies and the effect it has on gross margins; delays or decreases in capital spending in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact of general economic conditions on our sales and operations; our ability to develop new and enhanced products in a timely manner and market acceptance of our new or existing products; losses of one or more key customers; risks associated with our international operations;
exchange rate fluctuations of the currencies in which we conduct business; risks associated with our CableOS ™ and VOS ™ product solutions; dependence on market acceptance of various types of broadband services, on the adoption of new broadband technologies and on broadband industry trends; inventory management; the lack of timely availability of parts or raw materials necessary to produce our products; the impact of increases in the prices of raw materials and oil; the effect of competition, on both revenue and gross margins; difficulties associated with rapid technological changes in our markets; risks associated with unpredictable sales cycles; our dependence on contract manufacturers and sole or limited source suppliers; and the effect on our business of natural disasters.
It
is telling us only that there
is more supply of RMB than there
is demand for RMB
at the
current exchange rate.
There
are also user - friendly services such as Coinbase that will sell bitcoins to customers
at the
current exchange rate.
The luxury - goods group said 2017 fourth - quarter sales
were down 8.4 percent
at current exchange rates, hit by adverse currencies and an ongoing planned clearance of its product inventory.
Valuations
are converted to U.S. dollars
at current exchange rates... Read our complete methodology →
I have talked about this
at length elsewhere, and I
am sure that informed people
are well acquainted with the
current monetary policy regime in Australia, which
is based on an inflation target, an independent central bank and a floating
exchange rate.
If sellers want to buy in Bitcoins, the price will
be based on the day of the offer
at current value
rates according to the Canadian virtual
exchange and the weighted price of 12 hours.
On the other hand, for resource producers, production will
be highly profitable
at current exchange rates, given developments in resource prices.
With the dampening effect of the appreciation on domestic inflation still having further to run, our
current assessment
is that underlying inflation will decline to around 1 1/2 per cent during 2004 (assuming the
exchange rate remains stable
at around its
current level).
The official minimum wage in Ecuador
is 3,000 sucres per week, which works out to less than 600 sucres per day — or $ 1.50
at the
current exchange rate — as the average work week
is five and a half days.
With the crazy
exchange rate at the moment, $ 40million euros
is only 28.5
m GBP so he
is well within Wenger's price range, and if he continues to improve
at his
current rate then this could prove to
be a very solid investment for the club.
Don Balon list Griezmann's release clause
at $ 100m, though
current exchange rates have that as
being closer to # 88m as opposed to previous valuations of his fee in sterling.
Underpinning all this
is the sense that the Oyston's deliberately frugal approach to the Premier League
was been for their own benefit and profit, rather than the club's, a sense that
was reinforced in 2012 when it emerged that Karl had paid an # 11 milion salary ($ 16.7 million USD
at current exchange rates) to a company owned by his father, and a total of # 26 million to connected companies.
For me, though, the still images
are worth
at least several hundred words, depending on the
current exchange rate, and I encourage you to seek them out the next time something gloriously stupid like this happens.
The 27 year - old has a reported price tag of # 50m and
is said to have a salary bill of 10 million euros, (which as about the same as Arsene Wenger earns
at the
current exchange rate), but he has scored a very respectable 101 goals in his last 149 games which
is not a bad
rate of return, and he should
be worth every penny.
At current exchange rates, the fee
is short of the club record # 35m paid for Andy Carroll in 2011 but matches the sum they spent in 2016 to make Sadio Mane the most expensive African player.
Our
current total national debt
is US$ 28.37 billion which
at a
current exchange rate of US$ 1 to GHC 4.3 gives the GHC122 billion President Akufo Addo mentioned in his address.
The total cost of the Mars Express mission
is 300 million euros (about US $ 350 million
at current exchange rates), ESA officials say.
The total cost of the Mars Express mission, which blasted off in June 2003,
was about 300 million euros ($ 350 million
at current exchange rates), ESA officials have said.
When I go to Spain I usually take advantage of
being there to shop
at the biggest companies like Mango or Grupo Inditex, as it
's cheaper, and even more so with the
current exchange rate.
At the
current price and
exchange rates, it
's about $ 26 USD shipped to the United States and $ 36 CAD shipped to Canada.
By way of comparisons, the last few Marvel films to open in China
were Black Panther with $ 66 million, Captain America: Civil War with $ 98 million, and Avengers: Age of Ultron with $ 84 million (
at current exchange rates).
Before the movie begins, Sandra takes a leave of absence to combat clinical depression; when she tries to return to work (also before the movie begins), the boss, claiming to
be strapped for cash, forces her 16 co-workers to choose between receiving their annual bonus (about $ 1,400
at the
current exchange rate) or letting Sandra keep her job.
The F5 undercuts the Chiron by about # 1
m too (based on
current exchange rates), retailing
at $ 1.6
m.
The reproduction fabric will
be priced
at 184.45 Euros (roughly $ 229
at current exchange rates) per 1,000 x 1,400 mm (3.2 x 4.5 foot) sheet.
Each of the 20 coupes
are listed
at 2.2 million euros ($ 2.4 million
at current exchange rates), the 20 roadsters cost 2.4 million euros ($ 2.6 million) apiece, and the optional full carbon pack
is 100,000 euros ($ 111,000) extra.
The company's first concept
is an electric (no surprise there) SUV (nor there), which our sister site Auto Express suggests will have a starting price of around $ 45,000, or in the region of # 33,000
at current exchange rates.
Listed with an estimate of $ 1.8 - $ 2.4 million (around # 1.5 - # 2 million
at current exchange rates) it
's clear that Mazda
's rotary racers
are becoming coveted pieces of motorsport history.
When the car crosses the block in Monterey on August 19 it
's expected to make between $ 450k and $ 600k — around # 345k - # 460k
at current exchange rates.
Three will
be made, and they have already
been snapped up, despite the Veneno's asking price — three million euros plus local taxes (around # 3.1 million
at current exchange rates)-- making it over three times as costly as the # 866,000, 903bhp McLaren P1.
Using the option configurator, it
's possible to take the Velar past 100,000 pounds — $ 121,500
at current exchange rates.
On the British market the model will
be priced
at # 18,825 or about $ 30,000
at the
current exchange rates.
Prices start from $ 79,968 (including 19 percent VAT), which
is equivalent to $ 89,256
at the
current exchange rates.
Ford also announced the new
RS is now available to order with prices in Germany starting from $ 39,000 - about $ 43,000
at the
current exchange rates.
The TT
RS Plus Roadster has a list price of $ 63,500 ($ 84,500
at the
current exchange rates) with the manual transmission and $ 65,650 ($ 86,000
at the
current exchange rates) with the seven - speed
S tronic.
In Germany, the TT -
RS Coupe equipped with a manual transmission will
be priced
at $ 60,650 ($ 80,500
at the
current exchange rates) and $ 62,800 ($ 83,500
at the
current exchange rates) with the seven - speed
S - Tronic.
Humble as the B - Class appears to
be relative to the M5, the Northern Lights Black Edition
is as attractive as they come and can
be yours, assuming you live in Japan, for just ¥ 3.36 million, which
is about $ 33,900
at the
current exchange rates.
Pricing
is expected to slot in
at around 26,000 pounds in the U.K., or $ 35,114
at current exchange rates (1/10/2018).
Japan will
be receiving five of these special 2017 Corvette Grand Sport Admiral Blue Heritage Editions
at a price of 12,800,000 yen which
is equal to around $ 115,000 USD
at current exchange rates.
As far as the price tag
is concerned, those interested in buying the 2015 Subaru Levorg will have to settle for a starting sticker of # 27,495, or $ 42,840
at current exchange rates.
The E350 CDI Power Diesel Coupe
is priced
at $ 58,534 (roughly $ 75,800
at the
current exchange rates) and the CLS 350 CDI Power Diesel
is priced
at $ 68,879 ($ 89,100).